CSCO 2025 | Professor Ma Jun: 120 Years of Chinese Hematology Establishing a Global Benchmark – CSCO Annual Meeting to Decode Innovative Therapies and Cutting-Edge Breakthroughs
The 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) will be held in Jinan, Shandong, from September 10–14, 2025. This year’s meeting, themed “Standardized Diagnosis and Treatment,…
TCT Literature Express | Professors Ke Xiaoyan and Hu Kai: Preemptive CD20 CAR-T Therapy Prolongs Survival in Partial Responders after CD19 CAR-T
Relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) is a highly aggressive hematologic malignancy. In recent years, CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy has brought a revolutionary breakthrough for r/r…
ISEH 2025 | Professor Xue Feng: AAV Vector Gene Therapy Driving Innovation in Hemophilia B Treatment in China
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held in Kumamoto, Japan, from September 24 to 27. The event brought together leading global experts to discuss cutting-edge advances in basic hematology, immunology, stem cell biology, and cellular and gene therapies. One of the highlights of the meeting was the China–Japan Joint Symposium on Stem Cell and Cell Therapy, which drew significant attention. Professor Xue Feng from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (CAMS), delivered an insightful presentation titled “Adeno-Associated Virus Vector Expressing Factor IX Padua in Treating Hemophilia B in China.” Following the presentation, Oncology Frontier – Hematology Frontier conducted an exclusive interview with Professor Xue to explore this innovative approach and its future clinical prospects.
CSCO Experts’ Voice | Professor Jianming Guo: Outlook on the Development of China’s Prostate Cancer MDT Model and the Future of AI Applications
Editor’s Note: This September, the 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO 2025), one of China’s most prestigious oncology conferences, was successfully held in Jinan. During…